TapImmune to Provide Fourth Quarter and Full Year 2017 Business Update Conference Call and Webcast
COMPANY TO PROVIDE CORPORATE AND CLINICAL OVERVIEW ON THURSDAY, APRIL 5, 2018, 4:30PM ET
JACKSONVILLE, FLORIDA – March 29, 2017 – TapImmune Inc. (NASDAQ: TPIV), a leading clinical-stage immuno-oncology company with ongoing clinical trials in ovarian and breast cancer, today announced that the Company will host a conference call and live audio webcast on Thursday, April 5, 2018, at 4:30 p.m. ET, to provide a corporate and clinical update for the fourth quarter and year end 2017.
Reserve Your Seat: Register Today
The event will be webcast live via the Internet on:
April 5, 2018
4:30 PM ET
Click here to register today, or visit https://markertherapeutics.com/register/.
Day-of Call-in Information:
To access the live conference call on April 5, 2018, at 4:30pm ET you may use:
(855) 238-2333 (U.S.)
(412) 317-5215 (International)
To access the live audio webcast, visit the Events section of the TapImmune website: https://markertherapeutics.com/events. The webcast will also be archived for 90 days beginning at approximately 6:30 p.m. ET, on April 5, 2018.